Performance Biomechanics: Music To Scientists' Ears

Neurologist Frank Wilson’s first foray into music came at the age of 12, when he struggled through six months of the universal childhood ritual known as piano lessons. It wasn’t until many years later, however, while listening to his daughter rehearse for a piano recital around the time of her own 12th birthday, that his interests in music and the medical sciences converged. As she played Chopin’s “Fantasy Impromptu,” Wilson found himself for the first time rea

Written byJeff Seiken
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Neurologist Frank Wilson’s first foray into music came at the age of 12, when he struggled through six months of the universal childhood ritual known as piano lessons. It wasn’t until many years later, however, while listening to his daughter rehearse for a piano recital around the time of her own 12th birthday, that his interests in music and the medical sciences converged.

As she played Chopin’s “Fantasy Impromptu,” Wilson found himself for the first time really watching her hands. And the display of speed, dexterity, and timing he witnessed amazed him. His daughter’s fingers skipped across the keys in a blur. How could she make her fingers go so fast, he wondered. At least, that was his initial thought. His training in neurology soon led him to frame the question in terms more appropriate to his specialty: How does the brain control such highly skilled movement?

Shortly after this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies